About SynHelix
SynHelix is a company based in Evry-courcouronnes (France) founded in 2019 by Ahmed Said and Irina Gbalou was acquired by Univercells in January 2022.. SynHelix operates in a competitive market with competitors including Twist Bioscience, Nuclera Nucleics, Ansa Biotechnologies, Nutcracker Therapeutics and DNA Script, among others.
- Headquarter Evry-courcouronnes, France
- Founders Ahmed Said, Irina Gbalou
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Univercells
(Jan 06, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SynHelix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SynHelix
SynHelix has secured backing from 1 investor. Prominent investors backing the company include Univercells. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SynHelix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SynHelix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synhelix Comparisons
Competitors of SynHelix
SynHelix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Twist Bioscience, Nuclera Nucleics, Ansa Biotechnologies, Nutcracker Therapeutics and DNA Script, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
DNA synthesis technology using enzymes is provided.
|
|
| domain | founded_year | HQ Location |
mRNA therapeutics are developed via proprietary biochip platforms.
|
|
| domain | founded_year | HQ Location |
Benchtop DNA printers for nucleic acid synthesis are developed.
|
|
| domain | founded_year | HQ Location |
Developer of mRNA technology for therapeutics and vaccines
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about SynHelix
When was SynHelix founded?
SynHelix was founded in 2019.
Where is SynHelix located?
SynHelix is headquartered in Evry-courcouronnes, France. It is registered at Evry-courcouronnes, Essonne, France.
Who is the current CEO of SynHelix?
Irina Gbalou is the current CEO of SynHelix. They have also founded this company.
What does SynHelix do?
SynHelix was founded in 2019 in Evry Courcouronnes, France, within the biotechnology sector. An enzyme-based DNA synthesis solution is provided by the company, enabling gigaprep-scale production. This technology supports applications including cell and gene therapies, personalized diagnostics, and DNA vaccines. Operations focus on advancing DNA manufacturing processes for research and therapeutic uses.
Who are the top competitors of SynHelix?
SynHelix's top competitors include Nuclera Nucleics, Twist Bioscience and Ansa Biotechnologies.
Who are SynHelix's investors?
SynHelix has 1 investor. Key investors include Univercells.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.